Indo US Bio-Tech standalone net profit rises 161.08% in the September 2024 quarter
Sales rise 40.23% to Rs 22.17 crore
Net profit of Indo US Bio-Tech rose 161.08% to Rs 4.36 crore in the quarter ended September 2024 as against Rs 1.67 crore during the previous quarter ended September 2023. Sales rose 40.23% to Rs 22.17 crore in the quarter ended September 2024 as against Rs 15.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales22.1715.81 40 OPM %23.1416.45 -PBDT4.632.19 111 PBT4.451.98 125 NP4.361.67 161Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2024 | 3:01 PM IST